Literature DB >> 16316395

Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection.

S M Best1, M E Bloom.   

Abstract

Aleutian mink disease parvovirus (ADV) is an unusual member of the autonomous parvoviruses in both its replication and pathogenesis. Infection of newborn mink kits results in an acute disease typified by virus replication in type II pneumocytes in the lung. This replication is permissive and cytopathic, characterized by the production of high levels of viral replicative intermediates and infectious progeny. However, infection of adult Aleutian mink leads to a chronic form of the disease termed Aleutian disease (AD). In this case, virus replication occurs predominantly in lymph node macrophages and is restricted, with viral DNA replication, RNA transcription, protein expression and production of infectious progeny occurring at low levels. B19 is the only autonomous parvovirus known to infect humans. The primary site of virus replication in both children and adults is in erythrocyte precursors in the blood and bone marrow, although viral genomes have been detected in various other tissues. B19 infection often causes a self-limiting disease although persistent infection of B19 can occur in both immuno-compromised and -competent people. Perhaps the most striking similarity between infection with ADV or with B19 is the important role the humoral immune response to infection has in pathogenesis. It can be both protective and pathogenic. Due to of the central role of antibody in the disease caused by either virus, understanding the specific roles of antibody production in protection, antibody-mediated enhancement of infection, the establishment of persistent infection and immune-mediated pathology will provide insight into the pathogenesis of these infections. A second similarity between the two viruses is the ability to establish persistent infection. Persistence of ADV is associated with restricted replication. Although many cellular factors may contribute to restricted virus replication, the interactions between the major non-structural protein, NS1, and the cells are likely to be critical. Parallels exist between the expression and post-translational modification of ADV and B19 NS1 proteins that may contribute to restriction of virus replication. Thus, a study of the regulation of NS1 expression and its interactions with cell signalling pathways may lead to increased understanding of the restricted replication of these two viruses, and perhaps of persistent infection.

Entities:  

Mesh:

Year:  2005        PMID: 16316395     DOI: 10.1111/j.1439-0450.2005.00864.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  5 in total

1.  Internal polyadenylation of parvoviral precursor mRNA limits progeny virus production.

Authors:  Qinfeng Huang; Xuefeng Deng; Sonja M Best; Marshall E Bloom; Yi Li; Jianming Qiu
Journal:  Virology       Date:  2012-02-21       Impact factor: 3.616

2.  Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcoma.

Authors:  Marta Canuti; Cathy V Williams; Sashi R Gadi; Maarten F Jebbink; Bas B Oude Munnink; Seyed Mohammad Jazaeri Farsani; John M Cullen; Lia van der Hoek
Journal:  Front Microbiol       Date:  2014-12-01       Impact factor: 5.640

3.  Molecular analysis of carnivore Protoparvovirus detected in white blood cells of naturally infected cats.

Authors:  Andrea Balboni; Francesca Bassi; Stefano De Arcangeli; Rosanna Zobba; Carla Dedola; Alberto Alberti; Mara Battilani
Journal:  BMC Vet Res       Date:  2018-02-05       Impact factor: 2.741

Review 4.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

5.  Long-term antibody production and viremia in American mink (Neovison vison) challenged with Aleutian mink disease virus.

Authors:  A Hossain Farid; Irshad Hussain; Priyanka P Rupasinghe; Jancy Stephen; Irin Arju
Journal:  BMC Vet Res       Date:  2022-10-03       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.